terarecon logo
Free Trial

Customer Services 

Learning Center

About Us
    Menu
    Free Trial

    News / Multiple Sclerosis

    Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI

    by TeraRecon, on Apr 27, 2023, 3:49:24 PM

    Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI

    CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep learning technology necessary to bring …

    Read Story
    Prev All Posts Next

    About TeraRecon

    TeraRecon is a leader in advanced visualization, artificial intelligence, image viewing, and post-processing.

    Learn More →

    Subscribe to Receive News Updates

    TeraRecon, Inc

    TeraRecon Headquarters
    39650 Liberty St, Ste 370,
    Fremont, CA 94538

    info@terarecon.com 

     

    All offerings are subject to availability and regulatory clearance, which may vary by country. Please verify product status with your local TeraRecon representative.

     

    Additional Resources

    Subscribe to our newsletter

    ©2025 Terarecon, Inc. All Rights Reserved.